Home LiteratureArticle Details
PMID: 18838178 Published · ppublish English Journal Article Research Support, N.I.H., Intramural Review

Conformational changes involved in G-protein-coupled-receptor activation.

Trends in pharmacological sciences ·Vol. 29 ·No. 12 ·2008-12-00 ·Pages 616-25

Wess J, Han SJ, Kim SK, Jacobson KA, Li JH

Abstract

Little is known about the nature of the conformational changes that convert G-protein-coupled receptors (GPCRs), which bind diffusible ligands, from their resting into their active states. To gain structural insight into this process, various laboratories have used disulfide cross-linking strategies involving cysteine-substituted mutant GPCRs. Several recent disulfide cross-linking studies using the M(3) muscarinic acetylcholine receptor as a model system have led to novel insights into the conformational changes associated with the activation of this prototypical class I GPCR. These structural changes are predicted to involve multiple receptor regions, primarily distinct segments of transmembrane helices III, VI and VII and helix 8. Given the high degree of structural homology found among most GPCRs, it is likely that these findings will be of considerable general relevance. A better understanding of the molecular mechanisms underlying GPCR activation might lead to novel strategies aimed at modulating GPCR function for therapeutic purposes.

MeSH Terms
Animals Binding Sites Cysteine/metabolism Disulfides/metabolism Humans Ligands Models, Molecular Protein Conformation Receptor, Muscarinic M3/agonists,chemistry,metabolism
Chemicals
Disulfides Ligands Receptor, Muscarinic M3 Cysteine
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Wess Jürgen
Molecular Signaling Section and Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA. jwess@helix.nih.gov
Han Sung-Jun
Kim Soo-Kyung
Jacobson Kenneth A
Li Jian Hua
References (60)
60 references, click to expand
  1. Mutation of the fourth cytoplasmic loop of rhodopsin affects binding of transducin and peptides derived from the carboxyl-terminal sequences of transducin alpha and gamma subunits.
    J Biol Chem. 2000 Jan 21;275(3):1937-43 PMID: 10636895
  2. Uncovering molecular mechanisms involved in activation of G protein-coupled receptors.
    Endocr Rev. 2000 Feb;21(1):90-113 PMID: 10696571
  3. Mapping tertiary contacts between amino acid residues within rhodopsin.
    Methods Enzymol. 2000;315:130-43 PMID: 10736699
  4. Crystal structure of rhodopsin: A G protein-coupled receptor.
    Science. 2000 Aug 4;289(5480):739-45 PMID: 10926528
  5. Agonist-induced conformational changes in the G-protein-coupling domain of the beta 2 adrenergic receptor.
    Proc Natl Acad Sci U S A. 2001 May 22;98(11):5997-6002 PMID: 11353823
  6. Probing the dark state tertiary structure in the cytoplasmic domain of rhodopsin: proximities between amino acids deduced from spontaneous disulfide bond formation between Cys316 and engineered cysteines in cytoplasmic loop 1.
    Biochemistry. 2001 Oct 23;40(42):12472-8 PMID: 11601970
  7. Receptor activation: what does the rhodopsin structure tell us?
    Trends Pharmacol Sci. 2001 Nov;22(11):587-93 PMID: 11698103
  8. Conformational changes that occur during M3 muscarinic acetylcholine receptor activation probed by the use of an in situ disulfide cross-linking strategy.
    J Biol Chem. 2002 Jan 18;277(3):2247-57 PMID: 11698401
  9. Seven-transmembrane receptors: crystals clarify.
    Trends Pharmacol Sci. 2002 Mar;23(3):140-6 PMID: 11879682
  10. Rhodopsin: insights from recent structural studies.
    Annu Rev Biophys Biomol Struct. 2002;31:443-84 PMID: 11988478
  11. Use of an in situ disulfide cross-linking strategy to map proximities between amino acid residues in transmembrane domains I and VII of the M3 muscarinic acetylcholine receptor.
    Biochemistry. 2002 Jun 18;41(24):7647-58 PMID: 12056896
  12. Ligand sensitivity in dimeric associations of the serotonin 5HT2c receptor.
    EMBO Rep. 2008 Apr;9(4):363-9 PMID: 18344975
  13. Structural diversity of G protein-coupled receptors and significance for drug discovery.
    Nat Rev Drug Discov. 2008 Apr;7(4):339-57 PMID: 18382464
  14. Conformational changes in the parathyroid hormone receptor associated with activation by agonist.
    Mol Endocrinol. 2008 May;22(5):1154-62 PMID: 18258686
  15. Crystal structure of squid rhodopsin.
    Nature. 2008 May 15;453(7193):363-7 PMID: 18480818
  16. High-resolution distance mapping in rhodopsin reveals the pattern of helix movement due to activation.
    Proc Natl Acad Sci U S A. 2008 May 27;105(21):7439-44 PMID: 18490656
  17. Crystal structure of the ligand-free G-protein-coupled receptor opsin.
    Nature. 2008 Jul 10;454(7201):183-7 PMID: 18563085
  18. Seven-transmembrane receptors.
    Nat Rev Mol Cell Biol. 2002 Sep;3(9):639-50 PMID: 12209124
  19. Crosslinking of membrane-embedded cysteines reveals contact points in the EmrE oligomer.
    Proc Natl Acad Sci U S A. 2002 Sep 17;99(19):12043-8 PMID: 12221291
  20. Role of the conserved NPxxY(x)5,6F motif in the rhodopsin ground state and during activation.
    Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2290-5 PMID: 12601165
  21. Rhodopsin structure, dynamics, and activation: a perspective from crystallography, site-directed spin labeling, sulfhydryl reactivity, and disulfide cross-linking.
    Adv Protein Chem. 2003;63:243-90 PMID: 12629973
  22. Catalytic oxidation of sulfhydryl groups by o-phenanthroline copper complex.
    Biochim Biophys Acta. 1968 May;158(2):239-45 PMID: 4871609
  23. Rates of thiol-disulfide interchange reactions involving proteins and kinetic measurements of thiol pKa values.
    Biochemistry. 1980 Sep 2;19(18):4156-66 PMID: 6251863
  24. Thermal motions of surface alpha-helices in the D-galactose chemosensory receptor. Detection by disulfide trapping.
    J Mol Biol. 1992 Aug 20;226(4):1219-35 PMID: 1518053
  25. Fluorescent labeling of purified beta 2 adrenergic receptor. Evidence for ligand-specific conformational changes.
    J Biol Chem. 1995 Nov 24;270(47):28268-75 PMID: 7499324
  26. Pharmacology of a constitutively active muscarinic receptor generated by random mutagenesis.
    J Pharmacol Exp Ther. 1995 Dec;275(3):1274-9 PMID: 8531092
  27. Molecular biology of muscarinic acetylcholine receptors.
    Crit Rev Neurobiol. 1996;10(1):69-99 PMID: 8853955
  28. Requirement of rigid-body motion of transmembrane helices for light activation of rhodopsin.
    Science. 1996 Nov 1;274(5288):768-70 PMID: 8864113
  29. Light-induced exposure of the cytoplasmic end of transmembrane helix seven in rhodopsin.
    Proc Natl Acad Sci U S A. 1998 Oct 27;95(22):12854-9 PMID: 9789004
  30. Molecular basis of receptor/G-protein-coupling selectivity.
    Pharmacol Ther. 1998 Dec;80(3):231-64 PMID: 9888696
  31. Molecular tinkering of G protein-coupled receptors: an evolutionary success.
    EMBO J. 1999 Apr 1;18(7):1723-9 PMID: 10202136
  32. Use of a disulfide cross-linking strategy to study muscarinic receptor structure and mechanisms of activation.
    J Biol Chem. 1999 Jun 4;274(23):16629-40 PMID: 10347230
  33. Single-cysteine substitution mutants at amino acid positions 306-321 in rhodopsin, the sequence between the cytoplasmic end of helix VII and the palmitoylation sites: sulfhydryl reactivity and transducin activation reveal a tertiary structure.
    Biochemistry. 1999 Jun 22;38(25):7925-30 PMID: 10387034
  34. Structural features and light-dependent changes in the sequence 306-322 extending from helix VII to the palmitoylation sites in rhodopsin: a site-directed spin-labeling study.
    Biochemistry. 1999 Jun 22;38(25):7931-7 PMID: 10387035
  35. Identification and molecular characterization of m3 muscarinic receptor dimers.
    J Biol Chem. 1999 Jul 2;274(27):19487-97 PMID: 10383466
  36. Identification of an agonist-induced conformational change occurring adjacent to the ligand-binding pocket of the M(3) muscarinic acetylcholine receptor.
    J Biol Chem. 2005 Oct 14;280(41):34849-58 PMID: 16093246
  37. Crosstalk in G protein-coupled receptors: changes at the transmembrane homodimer interface determine activation.
    Proc Natl Acad Sci U S A. 2005 Nov 29;102(48):17495-500 PMID: 16301531
  38. Constitutive activity and inverse agonism at the M2 muscarinic acetylcholine receptor.
    J Pharmacol Exp Ther. 2006 Jan;316(1):279-88 PMID: 16188951
  39. Molecular mechanism of 7TM receptor activation--a global toggle switch model.
    Annu Rev Pharmacol Toxicol. 2006;46:481-519 PMID: 16402913
  40. Molecular basis of inverse agonism in a G protein-coupled receptor.
    Nat Chem Biol. 2005 Jun;1(1):25-8 PMID: 16407989
  41. Use of an in situ disulfide cross-linking strategy to study the dynamic properties of the cytoplasmic end of transmembrane domain VI of the M3 muscarinic acetylcholine receptor.
    Biochemistry. 2006 Jan 24;45(3):676-85 PMID: 16411743
  42. Role of the PAR1 receptor 8th helix in signaling: the 7-8-1 receptor activation mechanism.
    J Biol Chem. 2006 Feb 17;281(7):4109-16 PMID: 16354660
  43. Quantitative analysis of muscarinic acetylcholine receptor homo- and heterodimerization in live cells: regulation of receptor down-regulation by heterodimerization.
    J Biol Chem. 2006 Mar 3;281(9):5416-25 PMID: 16368694
  44. Conformational states and dynamics of rhodopsin in micelles and bilayers.
    Biochemistry. 2006 May 2;45(17):5538-50 PMID: 16634635
  45. Characterization of the residues in helix 8 of the human beta1-adrenergic receptor that are involved in coupling the receptor to G proteins.
    J Biol Chem. 2006 May 5;281(18):12896-907 PMID: 16500896
  46. Metal ion site engineering indicates a global toggle switch model for seven-transmembrane receptor activation.
    J Biol Chem. 2006 Jun 23;281(25):17337-46 PMID: 16567806
  47. Crystal structure of a photoactivated deprotonated intermediate of rhodopsin.
    Proc Natl Acad Sci U S A. 2006 Oct 31;103(44):16123-8 PMID: 17060607
  48. G protein coupled receptor structure and activation.
    Biochim Biophys Acta. 2007 Apr;1768(4):794-807 PMID: 17188232
  49. Conformational complexity of G-protein-coupled receptors.
    Trends Pharmacol Sci. 2007 Aug;28(8):397-406 PMID: 17629961
  50. Distinct structural changes in a G protein-coupled receptor caused by different classes of agonist ligands.
    J Biol Chem. 2007 Sep 7;282(36):26284-93 PMID: 17623649
  51. Crystal structure of the human beta2 adrenergic G-protein-coupled receptor.
    Nature. 2007 Nov 15;450(7168):383-7 PMID: 17952055
  52. GPCR engineering yields high-resolution structural insights into beta2-adrenergic receptor function.
    Science. 2007 Nov 23;318(5854):1266-73 PMID: 17962519
  53. High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor.
    Science. 2007 Nov 23;318(5854):1258-65 PMID: 17962520
  54. Sequence of late molecular events in the activation of rhodopsin.
    Proc Natl Acad Sci U S A. 2007 Dec 18;104(51):20290-5 PMID: 18077356
  55. Activation of G protein-coupled receptors: beyond two-state models and tertiary conformational changes.
    Annu Rev Pharmacol Toxicol. 2008;48:107-41 PMID: 17848137
  56. Ligand-specific changes in M3 muscarinic acetylcholine receptor structure detected by a disulfide scanning strategy.
    Biochemistry. 2008 Mar 4;47(9):2776-88 PMID: 18247581
  57. Conformational changes in G-protein-coupled receptors-the quest for functionally selective conformations is open.
    Br J Pharmacol. 2008 Mar;153 Suppl 1:S358-66 PMID: 18059316
  58. Agonist-induced conformational changes in thyrotropin-releasing hormone receptor type I: disulfide cross-linking and molecular modeling approaches.
    Biochemistry. 2005 Feb 22;44(7):2419-31 PMID: 15709754
  59. Methods to monitor the quaternary structure of G protein-coupled receptors.
    FEBS J. 2005 Jun;272(12):2914-25 PMID: 15955052
  60. Pronounced conformational changes following agonist activation of the M(3) muscarinic acetylcholine receptor.
    J Biol Chem. 2005 Jul 1;280(26):24870-9 PMID: 15870064
Article Info
Journal
Trends in pharmacological sciences
Abbr.
Trends Pharmacol Sci
ISSN
0165-6147
Published
2008-12-00
Epub
2008-00-04
Pages
616-25
Language
English
Region
England
NLM ID
7906158
PMCID
PMC3475190
Subset
IM
Grants
Intramural NIH HHS · Z01 DK031129-01 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com